Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards

Author(s): Willis Jordan, Vu Nicole

Issue: Jul/Aug 2026 - Volume 30, Number 4

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2026 Pg. 329-336	Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards Author(s): Willis Jordan, Vu Nicole
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2020 Pg. 451-458	Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Jan/Feb 2018 Pg. 7-16	Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
May/Jun 2017 Pg. 223-228	Basics of Sterile Compounding: Manipulating Peptides and Proteins Author(s): Akers Michael J
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Jul/Aug 2020 Pg. 270-276	Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
May/Jun 2021 Pg. 206-209	FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Author(s): Brunner Scott
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Jan/Feb 2016 Pg. 29-36	Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Author(s): Pritchett Jon, Mixon William, O'Connell Kevin
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 99-104	Root Cause Analysis, Part 2: Sterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
May/Jun 2004 Pg. 206-209	Basics of Compounding for Cold Sores or Fever Blisters Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 453-463	Applying Quality of Design Concepts to Pharmacy Compounding Author(s): Timko Robert J
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin

Abstract

Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards

Page(s): 329-336

Abstract

Related Keywords

Related Categories

Related Articles from IJPC